The Use of Benzodiazepines among Kratom (Mitragyna Speciosa Korth.) Users

References

• Abdullah, A. F. L., A. A. Abraham, M. Sulaiman, and V. Kunalan. 2012. Forensic drug profiling of erimin-5 using TLC and GC-MS. Malaysian Journal of Forensic Sciences 3 (1):11–15.
   Google Scholar
• Ahmad, K., and Z. Aziz. 2012. Mitragyna speciosa use in the northern states of Malaysia: A cross-sectional study. Journal of Ethnopharmacoly 141:446–50. doi:10.1016/j.jep.2012.03.009.
   PubMed Web of Science ®Google Scholar
• Anwar, M., R. Law, and J. Schier. 2016. Notes from the field: Kratom (Mitragyna speciosa) exposures reported to poison centers-United States, 2010-2015. Centers for Disease Control and Prevention (CDC) 65 (29):748–49.
   Google Scholar
• Boyer, E. W., K. M. Babu, J. E. Adkins, C. R. McCurdy, and J. H. Halpern. 2008. Self-treatment of opioid withdrawal using kratom (Mitragyna speciosa korth). Addiction 103:1048–50. doi:10.1111/j.1360-0443.2008.02209.x.
   PubMed Web of Science ®Google Scholar
• Chongrattanakon, N., B.-O. Thepthien, and S. A. Hong. 2018. Prevalence and psycho-social determinants of Kratom (Mitragyna speciosa) juice cocktail consumption among youth in Surat Thani Province, Thailand. Journal of Substance Use 23 (2). doi:10.1080/14659891.2017.1378735.
   Web of Science ®Google Scholar
• Domingo, O., G. Roider, A. Stover, M. Graw, F. Musshoff, H. Sachs, and W. Bicker. 2017. Mitragynine concentrations in two fatalities. Forensic Science International 271:e1–7. doi:10.1016/j.forsciint.2016.12.020.
   PubMed Web of Science ®Google Scholar
• DuPont, R. L. 1990. A physician’s guide to discontinuing benzodiazepine therapy. The Western Journal of Medicine 152 (5):600–03.
   PubMedGoogle Scholar
• Forrester, M. B. 2013. Kratom exposures reported to texas poison centers. Journal of Addictive Diseases 32:396–400. doi:10.1080/10550887.2013.854153.
   PubMed Web of Science ®Google Scholar
• Griffiths, R. R., and E. M. Weerts. 1997. Benzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abuse. Psychopharmacology 134:1–37.
   PubMed Web of Science ®Google Scholar
• Grundmann, O. 2017. Patterns of Kratom use and health impact in the US-Results from an online survey. Drug and Alcohol Dependence 176:63–70. doi:10.1016/j.drugalcdep.2017.03.007.
   PubMed Web of Science ®Google Scholar
• Henningfield, J. E., R. V. Fant, and D. W. Wang. 2018. The abuse potential of kratom according the 8 factors of the controlled substances act: Implications for regulation and research. Psychopharmacology 235 (2):573–89. doi:10.1007/s00213-017-4813-4.
   PubMed Web of Science ®Google Scholar
• Holler, J. M., S. P. Vorce, P. C. McDonough-Bender, J. Magluilo, C. J. Solomon, and B. Levine. 2011. A drug toxicity death involving propylhexedrine and mitragynine. Journal of Analytical Toxicology 35:54–59. doi:10.1093/anatox/35.1.54.
   PubMed Web of Science ®Google Scholar
• Idayu, F. I., M. T. Hidayat, M. A. M. Moklas, F. Sharida, A. R. N. Raudzah, A. R. Shamima, and E. Apryani. 2011. Antidepressant-like effect of mitragynine isolated from Mitragyna speciosa Korth in mice model of depression. Phytomedicine 18:402–07. doi:10.1016/j.phymed.2010.08.011.
   PubMed Web of Science ®Google Scholar
• Khor, B. S., M. F. Jamil, M. I. Adenan, and A. C. Shu-Chien. 2011. Mitragynine attenuates withdrawal syndrome in morphine-withdrawn zebrafish. PLoS One 6 (12):e28340. doi:10.1371/journal.pone.0028340.
   PubMed Web of Science ®Google Scholar
• Kronstrand, R., M. Roman, G. Thelander, and A. Eriksson. 2011. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend krypton. Journal of Analytical Toxicology 35:242–47. doi:10.1093/anatox/35.4.242.
   PubMed Web of Science ®Google Scholar
• Kruegel, A. C., M. M. Gassaway, A. Kapoor, A. Váradi, S. Majumdar, M. Filizola, J. A. Javitch, and D. Sames. 2016. Synthetic and receptor signaling explorations of the mitragyna alkaloids: Mitragynine as an atypical molecular framework for opioid receptor modulators. Journal of the American Chemical Society 138 (21):6754–56. doi:10.1021/jacs.6b00360.
   PubMed Web of Science ®Google Scholar
• Likhitsathian, S., W. Jiraporncharoen, A. Aramrattana, C. Angkurawaranon, M. Srisurapanont, K. Thaikla, S. Assanangkornchai, M. Kanato, U. Perngparn, and R. Jarubenja. 2018. Polydrug use among kratom users: Findings from the 2011 Thailand National Household Survey. Journal of Substance Use 23 (4). doi:10.1080/14659891.2018.1436599.
   Web of Science ®Google Scholar
• Manda, V. K., B. Avula, O. R. Dale, Z. Ali, I. A. Khan, L. A. Walker, and S. I. Khan. 2017. PXR mediated induction of CYP3A4, CYP1A2, and P-gp by Mitragyna speciosa and its alkaloids. Phytotherapy Research 31:1935–45. doi:10.1002/ptr.5942.
   PubMed Web of Science ®Google Scholar
• Manda, V. K., B. Avula, Z. Ali, I. A. Khan, L. A. Walker, and S. I. Khan. 2014. Evaluation of in vitro absorption, distribution, metabolism, and excretion (adme) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline. Planta Med 80:568–576.
   PubMed Web of Science ®Google Scholar
• McIntyre, I. M., A. Trochta, S. Stolberg, and S. C. Campman. 2015. Mitragynine ‘Kratom’ related fatality: A case report with postmortem concentrations. Journal of Analytical Toxicology 39:152–55. doi:10.1093/jat/bku137.
   PubMed Web of Science ®Google Scholar
• McMahon, L. R. 2010. Nimetazepam. Encyclopedia of psychopharmacology. Berlin, Heidelberg: Springer.
   Google Scholar
• Neerman, M. F., R. E. Frost, and J. Deking. 2013. A drug fatality involving kratom. Journal of Forensic Science 58 (S1). doi:10.1111/1556-4029.12009.
   PubMedGoogle Scholar
• Nelsen, J. L., J. Lapoint, M. J. Hodgman, and K. M. Aldous. 2010. Seizure and coma following kratom (Mitragynina speciosa Korth) exposure. Journal of Medical Toxicology 6:424–26. doi:10.1007/s13181-010-0079-5.
   PubMedGoogle Scholar
• New Straits Times. 2017. https://www.nst.com.my/news/2017/03/219372/cop-score-big-seizure-rm50m-worth-erimin-pills.
   Google Scholar
• New Straits Times. 2018. https://www.nst.com.my/news/crime-courts/2018/09/411407/bukit-aman-close-down-erimin-5-pills-factory-seize-rm72mil-worth.
   Google Scholar
• Petursson, H., and M. H. Lader. 1981. Withdrawal from long-term benzodiazepine treatment. British Medical Journal 283:643–45. doi:10.1136/bmj.283.6292.643.
   PubMed Web of Science ®Google Scholar
• Saingam, D., S. Assanangkornchai, A. F. Geater, and Q. Balthip. 2012. Pattern and consequences of krathom (Mitragyna speciosa Korth.) use among male villagers in southern Thailand: A qualitative study. The International Journal on Drug Policy 24 (4):351–58. doi:10.1016/j.drugpo.2012.09.004.
   PubMed Web of Science ®Google Scholar
• Salzman, C. 1998. Addiction to benzodiazepines. Psychiatric Quaterly 69 (4):251–61. doi:10.1023/A:1022125929946.
   PubMed Web of Science ®Google Scholar
• Singh, D., S. Narayanan, and B. Vicknasingam. 2016. Traditional and non-traditional uses of Mitragynine (Kratom): A survey of the literature. Brain Research Bulletin 126:41–46. doi:10.1016/j.brainresbull.2016.05.004.
   PubMed Web of Science ®Google Scholar
• Singh, D., S. Narayanan, B. Vicknasingam, O. Corazza, R. Santacroce, and A. Roman-Urrestarazu. 2017. Changing trends in the use of kratom (Mitragyna speciosa) in Southeast Asia. Human Psychopharmacology: Clinical and Experimental e2582. doi:10.1002/hup.v32.3.
   Web of Science ®Google Scholar
• Smith, D. E., and M. J. Landry. 1990. Benzodiazepine dependency discontinuation: Focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse. Journal of Psychiatric Research 24 (2):145–56.
   PubMedGoogle Scholar
• Smith, K. E., and T. Lawson. 2017. Prevalence and motivations of kratom use in a sample of substance users enrolled in a residential treatment program. Drug and Alcohol Dependemce 180:340–48. doi:10.1016/j.drugalcdep.2017.08.034.
   PubMed Web of Science ®Google Scholar
• Srichana, K., B. Janchawee, S. Prutipanlai, P. Raungrut, and N. Keawpradub. 2015. Effects of mitragynine and crude alkaloid extract derived from mitragyna speciosa korth. on permethrin elimination in rats. Pharmaceutics 7:10–26. doi:10.3390/pharmaceutics7020010.
   PubMed Web of Science ®Google Scholar
• Suwanlert, S. 1975. A Study of Kratom Eaters in Thailand. Bulletin on Narcotics 27 (3):21–27.
   PubMedGoogle Scholar
• Swogger, M. T., E. Hart, F. Erowid, E. Erowid, N. Trabold, K. Yee, K. A. Parkhurst, B. M. Priddy, and Z. Walsh. 2015. Experiences of kratom users: A qualitative analysis. Journal of Psychoactive Drugs 47 (5):360–67. doi:10.1080/02791072.2015.1096434.
   PubMed Web of Science ®Google Scholar
• Tanguay, P. 2011. Kratom in Thailand: Decriminalisation and community control? Series on legislative reform of drug policies. International Drug Policy Consortium (IDPC) 13:1–16.
   Google Scholar
• Trakulsrichai, S., A. Tongpo, C. Sriapha, S. Wongvisawakorn, P. Rittilert, S. Kaojarern, and W. Wananukul. 2013. Kratom abuse in ramathibodi poison center, Thailand: A five-year experience. Journal Of Psychoactive Drugs 45 (5):404–408.
   PubMed Web of Science ®Google Scholar
• Tungtananuwat, W., and S. Lawanprasert. 2010. Fatal 4x100; Home-made kratom juice cocktail. Journal of Health Research 24 (1):43–47.
   Google Scholar
• Vicknasingam, B., S. Narayanan, G. T. Beng, and S. M. Mansor. 2010. The informal use of ketum (Mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy. International Journal of Drug Policy 21:283–88. doi:10.1016/j.drugpo.2009.12.003.
   PubMed Web of Science ®Google Scholar
• Wonguppa, R., and M. Kanato. 2018. The prevalence and associated factors of new psychoactive substance use: A 2016 Thailand national household survey. Addictive Behaviors Reports 7:111–15. doi:10.1016/j.abrep.2017.11.001.
   PubMedGoogle Scholar